Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06193577
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2023-12-06
Brief Title:
Effect of Phaseolus Vulgaris L Dry Extract on the Modulation of Weight and Metabolic Parameters
Sponsor:
IBSA Farmaceutici Italia Srl
Organization:
IBSA Farmaceutici Italia Srl
Study Overview
Official Title:
Single-centre Prospective Randomized Placebo-controlled Single-blind Clinical Trial to Evaluate the Efficacy of a Food Supplement Based on Phaseolus Vulgaris L Dry Extract on the Modulation of Weight and Metabolic Parameters
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluation of the efficacy of Phaseolus vulgaris L dry extract on weight modulation
Detailed Description:
Monocentric prospective randomized single-blind clinical trial to evaluate the effects of Phaseolus vulgaris L dry extract test on weight reduction and on metabolic parameters after 12 weeks of supplementation The efficacy on weight reduction will be evaluated in comparison with the placebo group control
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None